Avoiding harm and supporting autonomy are under-prioritised in cancer-screening policies and practices
- 4 September 2017
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 85, 1-5
- https://doi.org/10.1016/j.ejca.2017.07.056
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- “Informed choice” in a time of too much medicine—no panacea for ethical difficultiesBMJ, 2016
- Walking the tightrope: communicating overdiagnosis in modern healthcareBMJ, 2016
- Perspective: The risks of overdiagnosisNature, 2015
- The importance of values in evidence-based medicineBMC Medical Ethics, 2015
- Screening for Cancer: Advice for High-Value Care From the American College of PhysiciansAnnals of Internal Medicine, 2015
- The Harms of ScreeningJAMA Internal Medicine, 2014
- Women's views on overdiagnosis in breast cancer screening: a qualitative studyBMJ, 2013
- Shared decision-making: enhancing the clinical relevanceJournal of the Royal Society of Medicine, 2012
- Benefit of cervical screening at different ages: evidence from the UK audit of screening historiesBritish Journal of Cancer, 2003
- Is mass screening for breast cancer cost-effective?European Journal of Cancer, 1996